Dejun Wu

Dr. Dejun Wu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DWDejun Wu
Dejun Wu
YLYuqin Li
Yuqin Li
AXAnjun Xu
Anjun Xu
WTWenqing Tang
Wenqing Tang
BYBo Yu
Bo Yu
Circular RNAs (circRNAs) have been shown to play a crucial role in cancer occurrence and progression. This present work investigated the link between hsa_circ_0008234 and colon cancer. Data retrieved from GSE172229 was used to compare the circRNA profiles of colon cancer and surrounding non-tumorous tissues. The amount of RNA and protein in the molecules was determined using quantitative real-time PCR (qRT-PCR) and Western blot analysis, respectively. The cell proliferation ability was assessed using CCK8, EdU, colon formation, and nude mice tumorigenesis tests. Cell invasion and migration abilities were evaluated using transwell wound healing and mice lung metastasis model. Hsa_circ_0008234 piqued our interest because bioinformatics and qRT-PCR analyses revealed that it is upregulated in colon cancer tissue. Cell phenotypic studies suggest that hsa_circ_0008234 may significantly increase colon cancer cell aggressiveness. Mice experiments revealed that inhibiting hsa_circ_0008234 significantly reduced tumor growth and metastasis. Moreover, the fluorescence in situ hybridization experiment demonstrated that hsa_circ_0008234 is primarily found in the cytoplasm, implying that it potentially functions via a competitive endogenous RNA pathway. These findings indicated that hsa_circ_0008234 may act as a “molecular sponge” for miR-338-3p, increasing the expression of miR-338-target 3p’s ETS1. In addition, the traditional oncogenic pathway PI3K/AKT/mTOR signaling was found to be the potential downstream pathway of the hsa_circ_0008234/miR-338-3p/ETS1 axis. In conclusion, hsa_circ_0008234 increases colon cancer proliferation, infiltration, and migration via the miR-338-3p/ETS1/PI3K/AKT axis; therefore, it could serve as a target and a focus for colon cancer therapy.

13 December 2023 in EBioMedicine
Verified
Journal Article
Open access
ZCZhixue Chen
Zhixue Chen
WTWenqing Tang
Wenqing Tang
NFNana Feng
Nana Feng
MLMinzhi Lv
Minzhi Lv
FMFansheng Meng
Fansheng Meng
RXRuyi Xue
Ruyi Xue
Background Abnormal liver function was frequently observed in nonalcoholic fatty liver disease (NAFLD) patients infected with SARS-CoV-2. Our aim was to explore the effect of SARS-CoV-2 inactivated vaccines on liver function abnormality among NAFLD patients with COVID-19. Methods The multi-center retrospective cohort included 517 NAFLD patients with COVID-19 from 1 April to 30 June 2022. Participants who received 2 doses of the vaccine (n = 274) were propensity score matched (PSM) with 243 unvaccinated controls. The primary outcome was liver function abnormality and the secondary outcome was viral shedding duration. Logistic and Cox regression models were used to calculate the odds ratio (OR) and hazard ratio (HR) for the outcomes. Sensitivity analysis was conducted to assess robustness. Findings PSM identified 171 pairs of vaccinated and unvaccinated patients. Liver function abnormality was less frequent in the vaccinated group (adjusted OR, 0.556 [95% CI (confidence interval), 0.356-0.869], p = 0.010). Additionally, the vaccinated group demonstrated a lower incidence of abnormal bilirubin levels (total bilirubin: adjusted OR, 0.223 [95% CI, 0.072-0.690], p = 0.009; direct bilirubin: adjusted OR, 0.175 [95% CI, 0.080-0.384], p < 0.001) and shorter viral shedding duration (adjusted HR, 0.798 [95% CI, 0.641-0.994], p = 0.044) than the un-vaccinated group. Further subgroup analysis revealed similar results, while the sensitivity analyses indicated consistent findings. Interpretation SARS-CoV-2 vaccination in patients with NAFLD may reduce the risk of liver dysfunction during COVID-19. Furthermore, vaccination demonstrated beneficial effects on viral shedding in the NAFLD population.

12 September 2024 in Heliyon
Verified
Journal Article
Open access
HWHuibin Wu
Huibin Wu
YZYunjie Zhang
Yunjie Zhang
WTWenqing Tang
Wenqing Tang
MLMinzhi Lv
Minzhi Lv
ZCZhixue Chen
Zhixue Chen
RXRuyi Xue
Ruyi Xue
Clinical practice showed that many patients with SARS-CoV-2 infection presented with long COVID syndrome in digestive system. We sought to investigate the factor affecting the incidence of long COVID syndrome in digestive system. Patients with SARS-CoV-2 infection diagnosed at two centers of Zhongshan Hospital and one center of Shanghai Pudong Hospital from March 01, 2022 to May 31, 2022 were enrolled, collected in the hospital database, and followed up until March 30, 2023. The primary outcome of the study was the occurrence of post-acute sequelae of COVID-19 in the digestive system (long COVID syndrome). Modified Poisson regression was used to calculate the relative risk (RR). This cohort study included 494 patients with SARS-CoV-2 infection, 144 (29.1 %) patients developed liver function abnormality on admission. During the follow-up period, the primary study outcome occurred in 30 (20.8 %) of the group presenting with liver function abnormality on admission and in 20 (5.7 %) of the group without liver function abnormality on admission (adjusted, RR = 3.550, 95%CI: 2.099–6.006, P ≤ 0.001). Our study suggests that patients with COVID-19 who experience liver function abnormality on admission have an increased risk of developing long COVID syndrome in the digestive system.

29 November 2025 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
YLYuqin Li
Yuqin Li
LXLin Xu
Lin Xu
XLXiaolan Lu
Xiaolan Lu
BFBaiqing Fu
Baiqing Fu
QJQiuyu Jiang
Qiuyu Jiang
DWDejun Wu
Dejun Wu

29 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
AXAnjun Xu
Anjun Xu
YYYangliang Yang
Yangliang Yang
DWDejun Wu
Dejun Wu
Background There are several methods to treat hemorrhoids; however, the most efficient is rubber band ligation (RBL), and the current combination of RBL with endoscopy is called endoscopic rubber band ligation of hemorrhoids (ERBL). This study aimed to compare the efficacy and safety of ERBL and analyze the satisfaction of patients with hemorrhoids.Methods This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Two authors (Xu, Yang) independently searched PubMed, Web of Science, Cochrane Library, Embase, China National Knowledge Infrastructure, and WanFang in April 2022. All eligible Chinese and English records were included in the analysis. Meta-analysis was performed using Review Manager version 5.3.Results A total of 330 articles were identified. Ultimately, 12 articles were included in the analysis. Compared to the control group, patients who underwent ERBL had significantly improved postoperative pain (visual analog scale score) (mean difference = -1.26, 95% confidence interval [CI] [-1.85, -0.68], P < 0.001). Simultaneously, ERBL reduced the incidence of complications such as postoperative bleeding (odd ratio [OR] = 0.31, 95% CI [0.16, 0.62], P = 0.0008), urinary retention (OR = 0.27, 95% CI [0.09, 0.83], P = 0.02), and anal protrusion (OR = 0.09, 95% CI [0.02, 0.36], P = 0.0008). In the postoperative follow-up, compared with other surgical methods in the control group, ERBL significantly increased the effective rate of surgery (OR = 5.77, 95% CI [2.41, 13.78], P < 0.001), decreased the postoperative recurrence rate (OR = 0.39, 95% CI [0.21, 0.74], P = 0.004), and improved patient satisfaction with surgery (OR = 4.3, 95% CI [2.21, 8.37], P < 0.001).Conclusions ERBL improved postoperative pain, reduced complications, and improved postoperative satisfaction in patients with hemorrhoids. These findings are suitable for further research.

26 July 2023 in Research Square
Verified
Preprint
Open access
PDF file
DWDejun Wu
Dejun Wu
BFBaijie Feng
Baijie Feng
WSWei Su
Wei Su
WXWujun Xiong
Wujun Xiong
MXMing Xu
Ming Xu
YLYuqin Li
Yuqin Li
The authors have requested that this preprint be removed from Research Square.